Jun Lu
Corporate Officer/Principal en SHANDONG BOAN BIOTECHNOLOGY CO., LTD. .
Perfil
Jun Lu is currently the SVP & Head-Bio Technology Engineering at Shandong Boan Biotechnology Co., Ltd.
Prior to this, he worked as an Associate Director at Momenta Pharmaceuticals, Inc. from 2013 to 2015 and as a Senior Manager-Process Development at Ipsen Bioscience, Inc. from 2006 to 2013.
Mr. Lu received his undergraduate degree from Peking University in 1988, his graduate degree from the University of Southern California in 1997, and his MBA from The University of Chicago in 2003.
Cargos activos de Jun Lu
| Empresas | Cargo | Inicio |
|---|---|---|
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Corporate Officer/Principal | 09/03/2015 |
Antiguos cargos conocidos de Jun Lu.
| Empresas | Cargo | Fin |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2015 |
Ipsen Bioscience, Inc.
 Ipsen Bioscience, Inc. BiotechnologyHealth Technology Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA. | Corporate Officer/Principal | 01/03/2013 |
Formación de Jun Lu.
| Peking University | Undergraduate Degree |
| University of Southern California | Graduate Degree |
| The University of Chicago | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Ipsen Bioscience, Inc.
Ipsen Bioscience, Inc. BiotechnologyHealth Technology Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jun Lu